drugdevelopR: Planning of phase II/III drug development programs with optimal sample size allocation and Go/No-go decision rules in R. - Johannes Cepicka; Lukas D. Sauer; Marietta Kirchner; Meinhard Kieser; Stella Erdmann (SoftwareX, 2025)